Objectives: To identify subgroups of patients with distinct chemotherapy-induced vomiting (CIV) profiles; determine how these subgroups differ on several demographic, clinical, and symptom characteristics; and evaluate factors associated with chemotherapy-induced nausea and CIV profiles.
Sample & Setting: Adult patients (N = 1,338) receiving cancer chemotherapy.
Methods & Variables: Data were collected on demographic, clinical, and symptom characteristics.